Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - enalapril maleate - tafla - 10 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - enalapril maleate - tafla - 20 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - enalapril maleate - tafla - 5 mg

Evrópusambandið - íslenska - EMA (European Medicines Agency)

dynavax gmbh - lifrarbólga b yfirborðs mótefnavaka - lifrarbólga b - bóluefni - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - levosimendanum inn - innrennslisþykkni, lausn - 2,5 mg/ml

Evrópusambandið - íslenska - EMA (European Medicines Agency)

orion corporation - dexmedetomidine hydrochloride - meðvitandi sedation - psycholeptics - til róandi fullorðinsþjálfunaraðila sem krefjast róandi stigs ekki dýpra en vökva sem svar við munnlegri örvun (samsvarandi richmond agitation-sedation scale (rass) 0 til -3).

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - perphenazinum inn - húðuð tafla - 2 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - perphenazinum inn - húðuð tafla - 4 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - perphenazinum inn - húðuð tafla - 8 mg

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - spironolactonum inn - tafla - 100 mg